An in-depth look to Inhibrx Biosciences, Inc. operating, investing, and financing activities

INBX free cash flow for Q1 24 is -64.17 M USD. For 2023, INBX free cash flow was -197.9 M USD and operating cash flow was -193.31 M USD.